Shell Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.03M Sell
40,506
-49,152
-55% -$1.21M 0.1% 229
2025
Q2
$2.17M Buy
89,658
+34,178
+62% +$797K 0.08% 252
2025
Q1
$1.41M Sell
55,480
-1,965
-3% -$51.4K 0.07% 244
2024
Q4
$1.52M Sell
57,445
-2,756
-5% -$74.8K 0.07% 245
2024
Q3
$1.74M Buy
+60,201
New +$1.76M 0.08% 215
2024
Q1
$1.68M Sell
60,201
-41,441
-41% -$1.15M 0.08% 221
2023
Q4
$2.93M Sell
101,642
-24,435
-19% -$739K 0.14% 151
2023
Q3
$4.18M Sell
126,077
-32,949
-21% -$1.17M 0.17% 117
2023
Q2
$5.83M Sell
159,026
-20,452
-11% -$796K 0.23% 78
2023
Q1
$7.32M Buy
179,478
+2,136
+1% +$92.3K 0.3% 63
2022
Q4
$9.09M Sell
177,342
-33,264
-16% -$1.59M 0.4% 52
2022
Q3
$9.22M Sell
210,606
-51,456
-20% -$2.5M 0.36% 56
2022
Q2
$13.7M Buy
262,062
+31,714
+14% +$1.62M 0.41% 46
2022
Q1
$11.9M Sell
230,348
-75,438
-25% -$3.91M 0.28% 69
2021
Q4
$18.1M Buy
305,786
+2,671
+0.9% +$132K 0.37% 47
2021
Q3
$13M Sell
303,115
-92,337
-23% -$4.09M 0.29% 70
2021
Q2
$15.5M Sell
395,452
-224,194
-36% -$8.72M 0.3% 72
2021
Q1
$22.4M Sell
619,646
-21,810
-3% -$774K 0.45% 40
2020
Q4
$23.6M Sell
641,456
-40,968
-6% -$1.5M 0.49% 30
2020
Q3
$23.8M Sell
682,424
-4,182
-0.6% -$147K 0.55% 28
2020
Q2
$21.3M Sell
686,606
-145,445
-17% -$4.94M 0.53% 31
2020
Q1
$25.8M Sell
832,051
-53,354
-6% -$1.82M 0.72% 21
2019
Q4
$32.9M Sell
885,405
-33,438
-4% -$1.19M 0.71% 23
2019
Q3
$31.3M Sell
918,843
-56,770
-6% -$2.06M 0.72% 25
2019
Q2
$40.1M Sell
975,613
-53,095
-5% -$2.11M 0.89% 15
2019
Q1
$41.5M Sell
1,028,708
-43,227
-4% -$1.73M 0.91% 12
2018
Q4
$44.4M Sell
1,071,935
-85,947
-7% -$3.57M 1.11% 8
2018
Q3
$48.4M Sell
1,157,882
-113,070
-9% -$4.35M 0.96% 11
2018
Q2
$43.7M Sell
1,270,952
-160,000
-11% -$5.47M 0.9% 13
2018
Q1
$48.2M Buy
1,430,952
+127,662
+10% +$4.39M 0.96% 10
2017
Q4
$44.8M Buy
1,303,290
+139,527
+12% +$4.76M 0.89% 14
2017
Q3
$39.4M Sell
1,163,763
-115,645
-9% -$3.72M 0.88% 10
2017
Q2
$40.8M Sell
1,279,408
-3,768
-0.3% -$119K 0.87% 11
2017
Q1
$41.6M Buy
1,283,176
+20,706
+2% +$653K 0.92% 9
2016
Q4
$38.9M Sell
1,262,470
-161,173
-11% -$4.92M 0.91% 10
2016
Q3
$45.7M Sell
1,423,643
-58,040
-4% -$1.94M 0.95% 10
2016
Q2
$49.5M Buy
1,481,683
+109,782
+8% +$3.5M 1.15% 8
2016
Q1
$38.6M Sell
1,371,901
-41,455
-3% -$1.18M 0.92% 20
2015
Q4
$43.3M Sell
1,413,356
-489,796
-26% -$15.4M 1.02% 13
2015
Q3
$53.4M Buy
1,903,152
+236,784
+14% +$7.59M 0.85% 14
2015
Q2
$53M Sell
1,666,368
-377,069
-18% -$12.3M 1.06% 9
2015
Q1
$67.4M Buy
2,043,437
+65,890
+3% +$2.09M 1.17% 6
2014
Q4
$58.4M Buy
1,977,547
+74,395
+4% +$2.13M 0.94% 12
2014
Q3
$53.4M Sell
1,903,152
-27,430
-1% -$770K 0.83% 14
2014
Q2
$54.4M Buy
1,930,582
+28,569
+2% +$814K 0.84% 14
2014
Q1
$58M Buy
1,902,013
+11,144
+0.6% +$332K 0.96% 6
2013
Q4
$55M Sell
1,890,869
-186,193
-9% -$5.42M 0.94% 8
2013
Q3
$56.6M Sell
2,077,062
-165,852
-7% -$4.51M 1.04% 11
2013
Q2
$59.6M Buy
+2,242,914
New +$62M 1.13% 11

Other funds holding PFE

Shell Asset Management's PFE Position: Q3 2025 in Review

Shell Asset Management reduced its Pfizer (PFE) stake by 55% in Q3 2025, selling an estimated $1.21M and leaving 40,506 shares worth $1.03M. The position accounts for 0.1% of the portfolio, ranked #229.

Shell Asset Management first reported a position in PFE in Q2 2013 and has held it in 49 quarters since. The position peaked at $67.4M in Q1 2015. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Shell Asset Management held 40,506 shares of Pfizer worth $1.03M as of Q3 2025.
  • Shell Asset Management sold 49,152 Pfizer shares in Q3 2025, an estimated $1.21M.
  • Pfizer made up 0.1% of Shell Asset Management's portfolio in Q3 2025, its #229 holding.
  • Shell Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 49 quarters since.
  • Shell Asset Management's Pfizer position peaked at $67.4M in Q1 2015.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.